Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Faulkner

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 16, 2018
Personalized medicine: renewing the social science research agendaStuart Hogarth, Michael Hopkins, Alex Faulkner
Regenerative Medicine|March 24, 2021
Digital readiness in 3D bioprinting: software, governance and hospitals' proto-clinical interfacesEdison Bicudo, Alex Faulkner, Phoebe Li
Social Science & Medicine (1982)|December 25, 2016
Promissory identities: Sociotechnical representations & innovation in regenerative medicineJohn Gardner, Ruchi Higham, Alex Faulkner, et al.
Social Science & Medicine (1982)|March 18, 2020
Beyond the orthodox/CAM dichotomy: Exploring therapeutic decision making, reasoning and practice in the therapeutic landscapes of elite sports medicineCatherine Coveney, Alex Faulkner, Jonathan Gabe, et al.
Social Theory & Health : STH|April 1, 2020
Regulating Hybrids: 'Making a Mess' and 'Cleaning Up' in Tissue Engineering and Transpecies TransplantationNik Brown, Alex Faulkner, Julie Kent, et al.
Regenerative Medicine|November 7, 2015
Are there specific translational challenges in regenerative medicine? Lessons from other fieldsJohn Gardner, Alex Faulkner, Aurélie Mahalatchimy, et al.
BMJ (Clinical Research Ed.)|May 31, 2003
Human tissue engineered products--drugs or devices?Alex Faulkner, Ingrid Geesink, Julie Kent, et al.
Social Science & Medicine (1982)|February 20, 2017
Where biomedicalisation and magic meet: Therapeutic innovations of elite sports injury in British professional football and cyclingAlex Faulkner, Michael McNamee, Catherine Coveney, et al.
Social Science & Medicine (1982)|August 15, 2006
Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technologyAlex Faulkner, Julie Kent, Ingrid Geesink, et al.
Journal of Law and Society|April 26, 2012
The legal landscape for advanced therapies: material and institutional implementation of European Union rules in France and the United KingdomAurélie Mahalatchimy, Emmanuelle Rial-Sebbag, Virginie Tournay, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 16, 2018
Personalized medicine: renewing the social science research agendaStuart Hogarth, Michael Hopkins, Alex Faulkner
Regenerative Medicine|March 24, 2021
Digital readiness in 3D bioprinting: software, governance and hospitals' proto-clinical interfacesEdison Bicudo, Alex Faulkner, Phoebe Li
Social Science & Medicine (1982)|December 25, 2016
Promissory identities: Sociotechnical representations & innovation in regenerative medicineJohn Gardner, Ruchi Higham, Alex Faulkner, et al.
Social Science & Medicine (1982)|March 18, 2020
Beyond the orthodox/CAM dichotomy: Exploring therapeutic decision making, reasoning and practice in the therapeutic landscapes of elite sports medicineCatherine Coveney, Alex Faulkner, Jonathan Gabe, et al.
Social Theory & Health : STH|April 1, 2020
Regulating Hybrids: 'Making a Mess' and 'Cleaning Up' in Tissue Engineering and Transpecies TransplantationNik Brown, Alex Faulkner, Julie Kent, et al.
Regenerative Medicine|November 7, 2015
Are there specific translational challenges in regenerative medicine? Lessons from other fieldsJohn Gardner, Alex Faulkner, Aurélie Mahalatchimy, et al.
BMJ (Clinical Research Ed.)|May 31, 2003
Human tissue engineered products--drugs or devices?Alex Faulkner, Ingrid Geesink, Julie Kent, et al.
Social Science & Medicine (1982)|February 20, 2017
Where biomedicalisation and magic meet: Therapeutic innovations of elite sports injury in British professional football and cyclingAlex Faulkner, Michael McNamee, Catherine Coveney, et al.
Social Science & Medicine (1982)|August 15, 2006
Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technologyAlex Faulkner, Julie Kent, Ingrid Geesink, et al.
Journal of Law and Society|April 26, 2012
The legal landscape for advanced therapies: material and institutional implementation of European Union rules in France and the United KingdomAurélie Mahalatchimy, Emmanuelle Rial-Sebbag, Virginie Tournay, et al.
Pageof 3